Report Detail

Medical Devices & Consumables Global and United States Metagenomic Sequencing Service Market Report & Forecast 2022-2028

  • RnM4420464
  • |
  • 06 April, 2022
  • |
  • Global
  • |
  • 109 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

Summary:

Shotgun metagenomic sequencing allows researchers to comprehensively sample all genes in all organisms present in a given complex sample. The method enables microbiologists to evaluate bacterial diversity and detect the abundance of microbes in various environments.
Market Analysis and Insights: Global and United States Metagenomic Sequencing Service Market
This report focuses on global and United States Metagenomic Sequencing Service market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Metagenomic Sequencing Service market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Shotgun Metagenomic Sequencing accounting for % of the Metagenomic Sequencing Service global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Clinical Diagnostic was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Metagenomic Sequencing Service market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global Metagenomic Sequencing Service Scope and Market Size
Metagenomic Sequencing Service market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Metagenomic Sequencing Service market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Metagenomic Sequencing Service market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Metagenomic Sequencing Service market is segmented into
Shotgun Metagenomic Sequencing
16S rRNA Sequencing
Metatranscriptomics
Whole-Genome Sequencing & De Novo Assembly
Segment by Application, the Metagenomic Sequencing Service market is segmented into
Clinical Diagnostic
Gut Microbe Characterization
Drug Discovery
Biofuel
Agriculture
Others
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Metagenomic Sequencing Service Market Share Analysis
Metagenomic Sequencing Service market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Metagenomic Sequencing Service business, the date to enter into the Metagenomic Sequencing Service market, Metagenomic Sequencing Service product introduction, recent developments, etc.
The major vendors covered:
Illumina
Thermo Fisher Scientific
QIAGEN NV
PerkinElmer
Oxford Nanopore Technologies Plc
GATC Biotech
Enterome Bioscience
Quest Diagnostics
Roche
CLC Bio
Agilent Technologies
Macrogen
Helicos BioSciences


Table of Contents

    1 Study Coverage

    • 1.1 Metagenomic Sequencing Service Product Introduction
    • 1.2 Global Metagenomic Sequencing Service Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Metagenomic Sequencing Service Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global Metagenomic Sequencing Service Sales in Volume for the Year 2017-2028
    • 1.3 United States Metagenomic Sequencing Service Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States Metagenomic Sequencing Service Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States Metagenomic Sequencing Service Sales in Volume for the Year 2017-2028
    • 1.4 Metagenomic Sequencing Service Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States Metagenomic Sequencing Service in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of Metagenomic Sequencing Service Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 Metagenomic Sequencing Service Market Dynamics
      • 1.5.1 Metagenomic Sequencing Service Industry Trends
      • 1.5.2 Metagenomic Sequencing Service Market Drivers
      • 1.5.3 Metagenomic Sequencing Service Market Challenges
      • 1.5.4 Metagenomic Sequencing Service Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 Metagenomic Sequencing Service Market Segment by Type
      • 2.1.1 Shotgun Metagenomic Sequencing
      • 2.1.2 16S rRNA Sequencing
      • 2.1.3 Metatranscriptomics
      • 2.1.4 Whole-Genome Sequencing & De Novo Assembly
    • 2.2 Global Metagenomic Sequencing Service Market Size by Type
      • 2.2.1 Global Metagenomic Sequencing Service Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global Metagenomic Sequencing Service Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global Metagenomic Sequencing Service Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States Metagenomic Sequencing Service Market Size by Type
      • 2.3.1 United States Metagenomic Sequencing Service Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States Metagenomic Sequencing Service Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States Metagenomic Sequencing Service Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 Metagenomic Sequencing Service Market Segment by Application
      • 3.1.1 Clinical Diagnostic
      • 3.1.2 Gut Microbe Characterization
      • 3.1.3 Drug Discovery
      • 3.1.4 Biofuel
      • 3.1.5 Agriculture
      • 3.1.6 Others
    • 3.2 Global Metagenomic Sequencing Service Market Size by Application
      • 3.2.1 Global Metagenomic Sequencing Service Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global Metagenomic Sequencing Service Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global Metagenomic Sequencing Service Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States Metagenomic Sequencing Service Market Size by Application
      • 3.3.1 United States Metagenomic Sequencing Service Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States Metagenomic Sequencing Service Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States Metagenomic Sequencing Service Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global Metagenomic Sequencing Service Competitor Landscape by Company

    • 4.1 Global Metagenomic Sequencing Service Market Size by Company
      • 4.1.1 Top Global Metagenomic Sequencing Service Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global Metagenomic Sequencing Service Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global Metagenomic Sequencing Service Sales by Manufacturer (2017-2022)
      • 4.1.4 Global Metagenomic Sequencing Service Price by Manufacturer (2017-2022)
    • 4.2 Global Metagenomic Sequencing Service Concentration Ratio (CR)
      • 4.2.1 Metagenomic Sequencing Service Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Metagenomic Sequencing Service in 2021
      • 4.2.3 Global Metagenomic Sequencing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Metagenomic Sequencing Service Manufacturing Base Distribution, Product Type
      • 4.3.1 Global Metagenomic Sequencing Service Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers Metagenomic Sequencing Service Product Type
      • 4.3.3 Date of International Manufacturers Enter into Metagenomic Sequencing Service Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Metagenomic Sequencing Service Market Size by Company
      • 4.5.1 Top Metagenomic Sequencing Service Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Metagenomic Sequencing Service Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States Metagenomic Sequencing Service Sales by Players (2020, 2021 & 2022)

    5 Global Metagenomic Sequencing Service Market Size by Region

    • 5.1 Global Metagenomic Sequencing Service Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Metagenomic Sequencing Service Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global Metagenomic Sequencing Service Sales in Volume by Region: 2017-2022
      • 5.2.2 Global Metagenomic Sequencing Service Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global Metagenomic Sequencing Service Market Size in Value by Region (2017-2028)
      • 5.3.1 Global Metagenomic Sequencing Service Sales in Value by Region: 2017-2022
      • 5.3.2 Global Metagenomic Sequencing Service Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Metagenomic Sequencing Service Market Size YoY Growth 2017-2028
      • 6.1.2 North America Metagenomic Sequencing Service Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Metagenomic Sequencing Service Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Metagenomic Sequencing Service Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Metagenomic Sequencing Service Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Metagenomic Sequencing Service Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Metagenomic Sequencing Service Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Metagenomic Sequencing Service Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
      • 6.4.6 Colombia
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Metagenomic Sequencing Service Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Metagenomic Sequencing Service Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Illumina
      • 7.1.1 Illumina Corporation Information
      • 7.1.2 Illumina Description and Business Overview
      • 7.1.3 Illumina Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 Illumina Metagenomic Sequencing Service Products Offered
      • 7.1.5 Illumina Recent Development
    • 7.2 Thermo Fisher Scientific
      • 7.2.1 Thermo Fisher Scientific Corporation Information
      • 7.2.2 Thermo Fisher Scientific Description and Business Overview
      • 7.2.3 Thermo Fisher Scientific Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 Thermo Fisher Scientific Metagenomic Sequencing Service Products Offered
      • 7.2.5 Thermo Fisher Scientific Recent Development
    • 7.3 QIAGEN NV
      • 7.3.1 QIAGEN NV Corporation Information
      • 7.3.2 QIAGEN NV Description and Business Overview
      • 7.3.3 QIAGEN NV Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 QIAGEN NV Metagenomic Sequencing Service Products Offered
      • 7.3.5 QIAGEN NV Recent Development
    • 7.4 PerkinElmer
      • 7.4.1 PerkinElmer Corporation Information
      • 7.4.2 PerkinElmer Description and Business Overview
      • 7.4.3 PerkinElmer Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 PerkinElmer Metagenomic Sequencing Service Products Offered
      • 7.4.5 PerkinElmer Recent Development
    • 7.5 Oxford Nanopore Technologies Plc
      • 7.5.1 Oxford Nanopore Technologies Plc Corporation Information
      • 7.5.2 Oxford Nanopore Technologies Plc Description and Business Overview
      • 7.5.3 Oxford Nanopore Technologies Plc Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 Oxford Nanopore Technologies Plc Metagenomic Sequencing Service Products Offered
      • 7.5.5 Oxford Nanopore Technologies Plc Recent Development
    • 7.6 GATC Biotech
      • 7.6.1 GATC Biotech Corporation Information
      • 7.6.2 GATC Biotech Description and Business Overview
      • 7.6.3 GATC Biotech Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2017-2022)
      • 7.6.4 GATC Biotech Metagenomic Sequencing Service Products Offered
      • 7.6.5 GATC Biotech Recent Development
    • 7.7 Enterome Bioscience
      • 7.7.1 Enterome Bioscience Corporation Information
      • 7.7.2 Enterome Bioscience Description and Business Overview
      • 7.7.3 Enterome Bioscience Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2017-2022)
      • 7.7.4 Enterome Bioscience Metagenomic Sequencing Service Products Offered
      • 7.7.5 Enterome Bioscience Recent Development
    • 7.8 Quest Diagnostics
      • 7.8.1 Quest Diagnostics Corporation Information
      • 7.8.2 Quest Diagnostics Description and Business Overview
      • 7.8.3 Quest Diagnostics Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2017-2022)
      • 7.8.4 Quest Diagnostics Metagenomic Sequencing Service Products Offered
      • 7.8.5 Quest Diagnostics Recent Development
    • 7.9 Roche
      • 7.9.1 Roche Corporation Information
      • 7.9.2 Roche Description and Business Overview
      • 7.9.3 Roche Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2017-2022)
      • 7.9.4 Roche Metagenomic Sequencing Service Products Offered
      • 7.9.5 Roche Recent Development
    • 7.10 CLC Bio
      • 7.10.1 CLC Bio Corporation Information
      • 7.10.2 CLC Bio Description and Business Overview
      • 7.10.3 CLC Bio Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2017-2022)
      • 7.10.4 CLC Bio Metagenomic Sequencing Service Products Offered
      • 7.10.5 CLC Bio Recent Development
    • 7.11 Agilent Technologies
      • 7.11.1 Agilent Technologies Corporation Information
      • 7.11.2 Agilent Technologies Description and Business Overview
      • 7.11.3 Agilent Technologies Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2017-2022)
      • 7.11.4 Agilent Technologies Metagenomic Sequencing Service Products Offered
      • 7.11.5 Agilent Technologies Recent Development
    • 7.12 Macrogen
      • 7.12.1 Macrogen Corporation Information
      • 7.12.2 Macrogen Description and Business Overview
      • 7.12.3 Macrogen Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2017-2022)
      • 7.12.4 Macrogen Products Offered
      • 7.12.5 Macrogen Recent Development
    • 7.13 Helicos BioSciences
      • 7.13.1 Helicos BioSciences Corporation Information
      • 7.13.2 Helicos BioSciences Description and Business Overview
      • 7.13.3 Helicos BioSciences Metagenomic Sequencing Service Sales, Revenue and Gross Margin (2017-2022)
      • 7.13.4 Helicos BioSciences Products Offered
      • 7.13.5 Helicos BioSciences Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 Metagenomic Sequencing Service Industry Chain Analysis
    • 8.2 Metagenomic Sequencing Service Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 Metagenomic Sequencing Service Distributors
    • 8.3 Metagenomic Sequencing Service Production Mode & Process
    • 8.4 Metagenomic Sequencing Service Sales and Marketing
      • 8.4.1 Metagenomic Sequencing Service Sales Channels
      • 8.4.2 Metagenomic Sequencing Service Distributors
    • 8.5 Metagenomic Sequencing Service Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:
      Get latest Market Research Reports on Metagenomic Sequencing Service. Industry analysis & Market Report on Metagenomic Sequencing Service is a syndicated market report, published as Global and United States Metagenomic Sequencing Service Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Metagenomic Sequencing Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,850.00
      $7,700.00
      3,068.45
      6,136.90
      3,580.50
      7,161.00
      588,588.00
      1,177,176.00
      321,205.50
      642,411.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report